Trademark: 90752761
Status Date
Monday, March 4, 2024
Filing Date
Thursday, June 3, 2021
Published for Opposition
Tuesday, March 1, 2022
5 Pharmaceutical preparations for the treatment of spasticity resulting from multiple sclerosis, including relief of flexor spasms, concomitant pain, clonus, and muscular rigidity; pain relief medication
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 4 Granted
Mar 4, 2024
Sou Extension 4 Filed
Mar 4, 2024
Sou Teas Extension Received
Aug 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 29, 2023
Sou Extension 3 Granted
Aug 29, 2023
Sou Extension 3 Filed
Aug 29, 2023
Sou Teas Extension Received
Mar 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2023
Sou Extension 2 Granted
Mar 3, 2023
Sou Extension 2 Filed
Mar 3, 2023
Sou Teas Extension Received
Sep 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2022
Sou Extension 1 Granted
Aug 31, 2022
Sou Extension 1 Filed
Aug 31, 2022
Sou Teas Extension Received
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 26, 2022
Approved For Pub - Principal Register
Jan 25, 2022
Teas/Email Correspondence Entered
Jan 24, 2022
Correspondence Received In Law Office
Jan 24, 2022
Teas Response To Office Action Received
Jan 12, 2022
Notification Of Non-Final Action E-Mailed
Jan 12, 2022
Non-Final Action E-Mailed
Jan 12, 2022
Non-Final Action Written
Jan 7, 2022
Assigned To Examiner
Aug 26, 2021
New Application Office Supplied Data Entered
Jun 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
